726
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Symptoms and oxylipins in plasma before and after exposure to rooms in which individuals have both experienced and not experienced building-related symptoms – an exploratory study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 2756-2766 | Received 28 Jun 2021, Accepted 30 Sep 2021, Published online: 19 Oct 2021

References

  • Borg G, Borg E. 2001. A new generation of scaling methods: level-anchored ratio scaling. Psychologica. 28:15–45.
  • Claar D, Hartert TV, Peebles RS. 2015. The role of prostaglandins in allergic lung inflammation and asthma. Expert Rev Respir Med. 9:55–72. doi:10.1586/17476348.2015.992783.
  • Claeson A-S, Andersson H, Wikdahl F, Nyback MH, Nordin S. 2018. Comorbidity of airway inflammatory diseases in chemical and building-related intolerance. J Occup Environ Med. 60:295–300. doi:10.1097/JOM.0000000000001249.
  • Claeson A-S, Andersson L. 2017. Symptoms from masked acrolein exposure suggest altered trigeminal reactivity in chemical intolerance. Neurotoxicology. 60:92–98. doi:10.1016/j.neuro.2017.03.007.
  • Claeson A-S, Gouveia-Figueira S, Häggström J, Fowler CJ, Nording ML. 2017. Levels of oxylipins, endocannabinoids and related lipids in plasma before and after low-level exposure to acrolein in healthy individuals and individuals with chemical intolerance. Prostaglandins Leukot Essent Fat Acids. 121:60–67. doi:10.1016/j.plefa.2017.06.004.
  • de Luca C, Raskovic D, Pacifico V, Thai JCS, Korkina L. 2011. The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances. Int J Environ Res Public Health. 8(7):2770–2797. doi:10.3390/ijerph8072770.
  • Dennis EA, Norris PC. 2015. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 15:511–523. doi:10.1038/nri3859.
  • Edvardsson B, Stenberg B, Bergdahl J, Eriksson N, Lindén G, Widman L. 2008. Medical and social prognoses of non-specific building-related symptoms (sick building syndrome): a follow-up study of patients previously referred to hospital. Int Arch Occup Environ Health. 81(7):805–812. doi:10.1007/s00420-007-0267-z.
  • Ernstgård L, Bottai M, Johanson G, Sjögren B. 2019. Down-regulation of the inflammatory response after short-term exposure to low levels of chemical vapours. Occup Environ Med. 76:482–487.
  • Fisk WJ, Chan WR, Johnson AL. 2019. Does dampness and mold in schools affect health? Results of a meta‐analysis. Indoor Air. 29:1–8. doi:10.1111/ina.12588.
  • Gdek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. 2013. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep. 65:1655–1662. doi:10.1016/S1734-1140(13)71527-5.
  • Gouveia-Figueira S, Karimpour M, Bosson JA, Blomberg A, Unosson J, Pourazar J, Sandström T, Behndig AF, Nording ML. 2017. Mass spectrometry profiling of oxylipins, endocannabinoids, and N-acylethanolamines in human lung lavage fluids reveals responsiveness of prostaglandin E2 and associated lipid metabolites to biodiesel exhaust exposure. Anal Bioanal Chem. 409:2967–2980. doi:10.1007/s00216-017-0243-8.
  • Gouveia-Figueira S, Karimpour M, Bosson JA, Blomberg A, Unosson J, Sehlstedt M, Pourazar J, Sandström T, Behndig AF, Nording ML. 2018. Mass spectrometry profiling reveals altered plasma levels of monohydroxy fatty acids and related lipids in healthy humans after controlled exposure to biodiesel exhaust. Anal Chim Acta. 1018:62–69. doi:10.1016/j.aca.2018.02.032.
  • Gouveia-Figueira S, Nording ML. 2014. Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids. Anal Chem. 86:1186–1195. doi:10.1021/ac403352e.
  • Gouveia-Figueira S, Späth J, Zivkovic AM, Nording ML. 2015. Profiling the oxylipin and endocannabinoid metabolome by UPLC-ESI-MS/MS in human plasma to monitor postprandial inflammation. PLoS One. 10:1–29. doi:10.1371/journal.pone.0132042.
  • James MJ, Penglis PS, Caughey GE, Demasi M, Cleland LG. 2001. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response? Inflamm Res. 50:249–253. doi:10.1007/s000110050750.
  • Kanchongkittiphon W, Mendell MJ, Gaffin JM, Wang G, Phipatanakul W. 2015. Indoor environmental exposures and exacerbation of asthma: an update to the 2000 review by the institute of medicine. Environ Health Perspect. 123:6–20. doi:10.1289/ehp.1307922.
  • Korpi A, Järnberg J, Pasanen A-L. 2009. Microbial volatile organic compounds. Crit Rev Toxicol. 39:139–193. doi:10.1080/10408440802291497.
  • Kwon J-W, Park H-W, Kim WJ, Kim MG, Lee SJ. 2018. Exposure to volatile organic compounds and airway inflammation. Environ Health. 17:1–8. doi:10.1186/s12940-018-0410-1.
  • Lu C-Y, Ma Y-C, Lin J-M, Li CY, Lin RS, Sung FC. 2007. Oxidative stress associated with indoor air pollution and sick building syndrome-related symptoms among office workers in Taiwan. Inhal Toxicol. 19:57–65. doi:10.1080/08958370600985859.
  • Lucidi V, Ciabattoni G, Bella S, Barnes PJ, Montuschi P. 2008. Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis{star, open}. Free Radic Biol Med. 45:913–919. doi:10.1016/j.freeradbiomed.2008.06.026.
  • Lundström SL, Levänen B, Nording M, Klepczynska-Nyström A, Sköld M, Haeggström JZ, Grunewald J, Svartengren M, Hammock BD, Larsson BM, et al. 2011. Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure. PLoS One. 6:e23864. doi:10.1371/journal.pone.0023864.
  • Lundström SL, Yang J, Källberg HJ, Thunberg S, Gafvelin G, Haeggström JZ, Grönneberg R, Grunewald J, van Hage M, Hammock BD, et al. 2012. Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. PLoS One. 7(3):e33780. doi:10.1371/journal.pone.0033780
  • Maes M, Christophe A, Bosmans E, Lin A, Neels H. 2000. In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry. 47(10):910–920. doi:10.1016/S0006-3223(99)00268-1.
  • Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. 2011. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect. 119(6):748–756. doi:10.1289/ehp.1002410.
  • Norbäck D. 2009. An update on sick building syndrome. Curr Opin Allergy Clin Immunol. 9(1):55–59. doi:10.1097/ACI.0b013e32831f8f08.
  • Paustenbach DJ, Gaffney SH. 2006. The role of odor and irritation, as well as risk perception, in the setting of occupational exposure limits. Int Arch Occup Environ Health. 79(4):339–342. doi:10.1007/s00420-005-0021-3.
  • Sahlberg B, Norbäck D, Wieslander G, Gislason T, Janson C. 2012. Onset of mucosal, dermal, and general symptoms in relation to biomarkers and exposures in the dwelling: a cohort study from 1992 to 2002. Indoor Air. 22(4):331–338. doi:10.1111/j.1600-0668.2012.00766.x.
  • Sakellaris, I., Saraga, D., Mandin, C., Kluizenaar, Y., Fossati, S., Spinazzè, A., Cattaneo, A., Mihucz, V., Szigeti, T., Oliveira Fernandes, E., Kalimeri, K., Mabilia, R., Carrer, P., Bartzis, J., 2021. Association of subjective health symptoms with indoor air quality in European office buildings: The OFFICAIR project. Indoor Air 31, 426–439. https://doi.org/10.1111/ina.12749
  • Sundell J, Levin H, Nazaroff WW, Cain WS, Fisk WJ, Grimsrud DT, Gyntelberg F, Li Y, Persily AK, Pickering AC. 2011. Ventilation rates and health: multidisciplinary review of the scientific literature. Indoor Air. 21(3):191–204. doi:10.1111/j.1600-0668.2010.00703.x.
  • Veenaas C, Ripszam M, Glas B, Liljelind I, Claeson A-S, Haglund P. 2020. Differences in chemical composition of indoor air in rooms associated/not associated with building related symptoms. Sci Total Environ. 720:137444. doi:10.1016/j.scitotenv.2020.137444.
  • Wang T, Han Y, Li H, Wang Y, Xue T, Chen X, Chen W, Fan Y, Qiu X, Gong J. 2021. Changes in bioactive lipid mediators in response to short-term exposure to ambient air particulate matter: a targeted lipidomic analysis of oxylipin signaling pathways. Environ Int. 147:106314. doi:10.1016/j.envint.2020.106314.
  • WHO. 1983. WHO. Indoor air pollutants: exposure and health effects. Euro Reports and Studies 78. Copenhagen: World Health Organization; p. 1–42. doi:10.1016/j.buildenv.2007.10.021.
  • WHO. 2000. WHO, editor Euro reports and studies. Guidelines for Air Quality. Geneva: World Health Organization.
  • Zhang X, Sahlberg B, Wieslander G, Janson C, Gislason T, Norback D. 2012. Dampness and moulds in workplace buildings: associations with incidence and remission of sick building syndrome (SBS) and biomarkers of inflammation in a 10 year follow-up study. Sci Total Environ. 430:75–81. doi:10.1016/j.scitotenv.2012.04.040.
  • Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O’Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C. 2012. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics. 8(6):1102–1113. doi:10.1007/s11306-012-0417-5.